Cell autonomous expression of CXCL-10 in JAK2V617F-mutated MPN

被引：0

作者：

Tina M. Schnöder

Judith Eberhardt

Michael Koehler

Holger B. Bierhoff

Sönke Weinert

Akhilesh Datt Pandey

Subbaiah Chary Nimmagadda

Denise Wolleschak

Korinna Jöhrens

Thomas Fischer

Florian H. Heidel

机构：

[1] Universitätsklinikum Jena,Innere Medizin II, Hämatologie und Onkologie

[2] Leibniz Institute on Aging,Department of Hematology and Oncology

[3] Fritz-Lipmann-Institute,Department of Genetics

[4] Otto-von-Guericke University Medical Center,Department of Cardiology

[5] Friedrich-Schiller-University,Institut für Pathologie

[6] Otto-von-Guericke University Medical Center,Collaborative Research Cluster 854 (CRC854), Medical Faculty

[7] Charité-Universitätsmedizin Berlin,undefined

[8] University Hospital Magdeburg,undefined

来源：

Journal of Cancer Research and Clinical Oncology | 2017年 / 143卷

关键词：

CXCL10; IP10; MPN; PV; ET; MF; Inflammation;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：807 / 820

页数：13

共 50 条

[21] Identification of the Key Genes and Molecular Pathways in Essential Thrombocythemia Associated with JAK2V617F Mutation Using Bioinformatics Approach
Elbager, Sahar Gamal
Dowd, Amar A.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S360 - S361
[22] The relevance of HLA class II genes in JAK2 V617F-positive myeloproliferative neoplasms
Shivarov, Velizar
Tsvetkova, Gergana
Hadjiev, Evgueniy
Ivanova, Milena
HUMAN IMMUNOLOGY, 2023, 84 (03) : 199 - 207
[23] ???????Expression profiles analysis identifies specific interferon-stimulated signatures as potential diagnostic and predictive indicators of JAK2V617F+ myelofibrosis
Zhao, Yanhong
Wang, Di
Liang, Yipeng
Xu, Changlu
Shi, Lihong
Tong, Jingyuan
FRONTIERS IN GENETICS, 2022, 13
[24] JAK2V617F mutation and spontaneous megakaryocytic or erythroid colony formation in patients with essential thrombocythaemia (ET) or polycythaemia vera (PV)
Mustjoki, Satu
Borze, Ioana
Lasho, Terra L.
Alitalo, Riitta
Pardanani, Animesh
Knuutila, Sakari
Juvonen, Eeva
LEUKEMIA RESEARCH, 2009, 33 (01) : 54 - 59
[25] The PIM inhibitor AZD1208 synergizes with ruxolitinib to induce apoptosis of ruxolitinib sensitive and resistant JAK2-V617F-driven cells and inhibit colony formation of primary MPN cells
Mazzacurati, Lucia
Lambert, Que T.
Pradhan, Anuradha
Griner, Lori N.
Huszar, Dennis
Reuther, Gary W.
ONCOTARGET, 2015, 6 (37) : 40141 - 40157
[26] Insights into the Potential Mechanisms of JAK2V617F Somatic Mutation Contributing Distinct Phenotypes in Myeloproliferative Neoplasms
Gou, Panhong
Zhang, Wenchao
Giraudier, Stephane
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (03)
[27] Oxidative Stress Levels, JAK2V617F Mutational Status and Thrombotic Complications in Patients with Essential Thrombocythemia
Moisa, Cornel
Gaman, Mihnea Alexandru
Diaconu, Camelia Cristina
Gaman, Amelia Maria
REVISTA DE CHIMIE, 2019, 70 (08): : 2822 - 2825
[28] JAK2V617F allele burden is reduced by busulfan therapy: a new observation using an old drug
Kuriakose, Emil T.
Gjoni, Stefani
Wang, Y. Lynn
Baumann, Ruth
Jones, Amy V.
Cross, Nicholas C. P.
Silver, Richard T.
HAEMATOLOGICA, 2013, 98 (11) : E135 - E137
[29] Relation of JAK2 V617F allele burden and coronary calcium score in patients with essential thrombocythemia
Drofenik, Ajda
Blinc, Ales
Mijovski, Mojca Bozic
Pajic, Tadej
Vrtovec, Matjaz
Sever, Matjaz
RADIOLOGY AND ONCOLOGY, 2024, 58 (04) : 565 - 572
[30] JAK2 V617F-positive essential thrombocythemia with subsequent development of immune thrombocytopenia A case report
Oda, Yasuhiro
Sato, Shuku
Kanbe, Emiko
Kamata, Wataru
Okada, Satomi
Tamai, Yotaro
MEDICINE, 2019, 98 (44) : e17766

← 1 2 3 4 5 →